Prevention of recurrent amiodarone-induced hyperthyroidism by iodine;Prévention des récidives d'hyperthyroïdie à l'amiodarone par l'iode131

Archives des Maladies du Coeur et des Vaisseaux

Volumn 97, Issue 3, 2004, Pages 207-213

  Hermida, J S ^a   Jarry, G ^a   Tcheng, E ^a   Moullart, V ^a   Arlot, S ^a   Rey, J L ^a   Schvartz, C ^b  

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b INSTITUT JEAN GODINOT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; IODINE; IODINE 131;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; DRUG EFFICACY; DRUG INDICATION; DRUG INDUCED DISEASE; FEMALE; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTENSION; HYPERTENSIVE HEART DISEASE; HYPERTHYROIDISM; HYPOTHYROIDISM; IDIOPATHIC ATRIAL FIBRILLATION; IDIOPATHIC DISEASE; ISCHEMIC HEART DISEASE; MALE; PAROXYSMAL HEART ATRIUM FIBRILLATION; RECURRENT DISEASE; RECURRENT HYPERTHYROIDISM; RETREATMENT; VALVULAR HEART DISEASE;

ADULT; AGED; AGED, 80 AND OVER; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; FEMALE; HEART DISEASES; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; TACHYCARDIA, VENTRICULAR; THYROTROPIN; THYROXINE;

EID: 1842534847     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Borowski GD, Garofano CD, Rose LI et al. Effects of long-term amiodarone therapy on thyroid hormone levels and thyroid function. Am J Med 1985; 78: 443-5.
2. Martino E, Safran M, Aghini-Lombardi F et al. Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. Ann Intern Med 1984; 101: 28-34.
3. Martina E, Bartalena L, Bogazzi F, Braverman L. The effects of amiodarone on the thyroid. Endocr Rev 2001; 22: 240-54.
4. Bogazzi F, Bartalena L, Gasperi M, Braverman LE, Martino E. The various effects of amiodarone on thyroid function. Thyroid 2001; 11: 511-9.
5. Newmann CM, Price A, Davies DW, Gray TA, Weetman AP. Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy. Heart 1998; 79: 121-7.
6. Hamoir E, Meurisse M, Defechereux T et al. Surgical management of amiodarane-associated thyrotaxicosis: taa risky or too effective? World J Surg 1998; 22: 537-43.
7. Osman F, Franklyn JA, Sheppard MC, Gammage MD. Successful treatment of amiodarone-induced thyrotoxicosis. Circulation 2002; 105: 1275-7.
8. Chiovato L, Martino E, Tonacchera M et al. Studies on the in vitro cytatoxic effect of amiodarone. Endocrinology 1994; 134: 2277-82.
9. Leenhardt A, Milliez P, Extramania F, Collot M, Coumel Ph. Amiodarone is not definitively contraindicated in patients having experienced hyperthyroidism. Circulation 2001; 102: 3305 (Abstract).
10. Trip MD, Wiersinga W, Plomp TA. Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism. Am J Med 1991; 91: 507-11.
11. Cooper D. Radioiodine for hyperthyroidism. Where do we stand after 50 years? JAMA 1948; 280: 375-6.
12. Pauwels EK, Smit JW, Slats A, Bourguignon M, Overbeek F. Health effects of therapeutic use of 131l in hyperthyroidism. Q J Nucl Med 2000; 44: 333-9.
13. Allahabadia A, Daykin J, Sheppard MC, Gough SC, Franklyn JA. Radioiodine treatment of hyperthyroidism-pronostic factor of outcome. J Clin Endocrinol Metab 2001; 86: 3611-7.
14. Holm LE, Hall P, Wiklund K et al. Cancer risk after iodine-131 therapy far hyperthyraidism. J Natl Cancer Inst 1991; 83: 1072-7.
15. Ron E, Doody MM, Becker DV et al. Cancer mortality following treatment for adult hyperthyraidism. JAMA 1998; 280: 347-55.
16. Franklyn JA, Maisonneuve P, Sheppard M, Betteridge J, Boyle P. Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study. Lancet 1999; 353: 2111-5.